The rapid elimination of dying neurons and nonfunctional synapses in the brain is carried out by microglia, the resident myeloid cells of the brain. Here we show that microglia clearance activity in the adult brain is regionally regulated and depends on the rate of neuronal attrition. Cerebellar, but not striatal or cortical, microglia exhibited high levels of basal clearance activity, which correlated with an elevated degree of cerebellar neuronal attrition. Exposing forebrain microglia to apoptotic cells activated gene-expression programs supporting clearance activity. We provide evidence that the polycomb repressive complex 2 (PRC2) epigenetically restricts the expression of genes that support clearance activity in striatal and cortical microglia. Loss of PRC2 leads to aberrant activation of a microglia clearance phenotype, which triggers changes in neuronal morphology and behavior. Our data highlight a key role of epigenetic mechanisms in preventing microglia-induced neuronal alterations that are frequently associated with neurodegenerative and psychiatric diseases.
D evelopment and aging of the brain are associated with the attrition and loss of neurons 1 . Despite the overall low rate of neuronal death during adulthood, functionally distinct brain areas display significant differences in neuronal loss 2 . One of the brain regions displaying the most pronounced age-dependent neuronal loss is the cerebellum, where neuronal numbers start declining at the end of adolescence 3, 4 . The loss of neurons in the cerebellum contrasts with that of other brain structures, such as the striatum, cortex, and hippocampus, which stably maintain their size and neuronal numbers throughout adulthood 3, 5 .
The clearance of dying cells and debris in the brain is carried out by microglia, the brain-resident macrophages 6 . Brain-regionspecific differences in neuronal attrition suggest the possibility that microglia may fine-tune their clearance activity to the load of cell debris. Accordingly, the clearance activity of microglia must be suppressed in areas with low rates of neuronal death in the adult brain. Exacerbated activation of microglia has been shown to promote microglia-mediated neuronal attrition 7, 8 . These findings underscore the essential role of mechanisms that modulate microglia activation in the maintenance of brain integrity.
Here we show regional differences in microglia clearance activity in the adult brain and demonstrate the importance of the tight regulation of such clearance activity for normal brain function. We found that cerebellar microglia display a distinct clearance phenotype characterized by the expression of numerous genes supporting the engulfment and catabolism of cells and cellular debris. The cerebellar microglia phenotype is reminiscent of microglia during early brain development 9,10 as well as microglia associated with neurodegenerative disease [11] [12] [13] . In contrast, microglia in the striatum-which, like the cerebellum, is characterized by a rather homogenous neuron population-display a homeostatic surveillance phenotype 14, 15 .
We found that the suppression of clearance activity in striatal microglia has an epigenetic underpinning. The suppression of clearance genes in striatal microglia is governed by PRC2, which catalyzes the repressive chromatin modification histone H3 lysine 27 trimethylation (H3K27me3) 16 . Accordingly, microglia-specific ablation of PRC2 leads to the aberrant acquisition of a clearance phenotype in striatal and cortical microglia even in the absence of dying neurons. This aberrant clearance activation has a negative impact on neuronal morphology and associated neuron-mediated behaviors, leading to impaired motor responses, decreased learning and memory, and the development of anxiety and seizures in mice.
Results
Cerebellar microglia display cellular phenotypes and geneexpression patterns associated with cell clearance. We found that cerebellar microglia (cbMg), unlike microglia in the striatum (stMg), display morphological features and gene expression patterns that support clearance functions ( Fig. 1 and Supplementary  Fig. 1 ). cbMg in the adult mouse brain show a primed or phagocytic microglia phenotype [11] [12] [13] characterized by a less-ramified morphology, reduced branching sites ( Supplementary Fig. 1a ), decreased cell volume ( Supplementary Fig. 1b,c) , and an increase in CD68 + lysosome content ( Fig. 1a and Supplementary Fig. 1b,c) . A significant fraction of microglia in the cerebellum contain lysosomes carrying cell nuclei fragments as determined by the presence of DAPI + nuclear material ( Fig. 1b and Supplementary Fig. 1d ), which is indicative of apoptotic cell clearance 17 . The relatively high CD68 + lysosome content of cbMg is reminiscent of microglia in the dentate gyrus and olfactory bulb ( Supplementary Fig. 1b,c) , where ongoing neuronal turnover is associated with high rates of cell death in the adult brain 18 .
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To study gene expression in microglia in a minimally invasive fashion in vivo, we established a microglia-specific translating ribosome affinity purification 19 (TRAP) approach (Fig. 1c ). To generate microglia-specific TRAP mice, we bred mice that carry a loxPflanked STOP cassette (LSL) upstream of the eGFP-L10a coding sequence under the control of ubiquitously expressed eukaryotic translation elongation factor 1 alpha 1, Eef1a1 (Eef1a1 LSL.eGFPL10a/+ ), with mice that express Cre recombinase under the control of a microglia-specific gene promoter. The Cx3Cr1 CreErt2/+ strain was chosen based on the inducibility, selectivity, and highest efficiency of Cre expression in microglia in the adult brain ( Supplementary   Fig. 2 ). Notably, we show that the TRAP approach not only allows for region-specific analysis of microglia-enriched mRNA expression ( Supplementary Fig. 3 and Supplementary Table 1 ) but also precludes nonspecific microglia activation and concurrent upregulation of immediate early and pro-inflammatory genes that occur during commonly used microglia isolation approaches ( Supplementary Fig. 4 and Supplementary Table 2 ).
We found that cbMg display a substantial enrichment in mRNAs associated with cell clearance functions ( Fig. 1d ,e, Supplementary  Fig. 5a ,b, and Supplementary Table 3 ). In contrast, stMg are enriched in mRNAs encoding mature microglia-specific homeostatic -log 10 (P ) Fig. 1 | cbMg display a cell clearance phenotype. a, Left: CD68 + lysosome content (red) in IBA1 + microglia (green) in brain sections from 4-to 6-month-old wild-type mice (DAPI, blue). Scale bar, 10 μ m. Right: quantification of lysosomal area per microglia area (stMg: mean = 0.02437, s.e.m. = 0.01011; cbMg: mean = 0.1424, s.e.m. = 0.02527; P = 0.0166, F = 6.245, t 2 = 7.668; > 15 images per region from n = 3 mice). b, Left: DAPI content (blue) in CD68 + lysosomes (red) of IBA1 + microglia (green) was determined using 3D reconstruction (Imaris) from 4-to 6-month-old wild-type mice. Scale bar, 5 μ m. Representative reconstruction with side-scatter views. Arrows, DAPI + CD68 + lysosome, shown with a zoomed-in view. Right: quantification of percentage of microglia with DAPI + CD68 + lysosomes (stMg: mean = 0.1675, s.e.m. = 0.06029; cbMg: mean = 0.6960, s.e.m. = 0.0868; P = 0.0300, F = 2.077, t 2 = 5.639; > 200 cells per region from n = 3 mice). Bar graphs with individual data points show mean ± s.e.m. of two-tailed paired t tests. c, Schematic showing microglia-specific TRAP-sequencing. d, Left: heatmap with hierarchical clustering distances shows the variation in the expression levels (z-scored log 2 (RPKM)) of 733 stMg-and 297 cbMg-enriched genes identified by TRAP (DESeq2 software, n = 2 mice per age per region). Right: selected gene ontology (GO) annotations (Enrichr) enriched for stMg-or cbMg-enriched genes; dotted lines, P = 0.05. e, Genome browser views (in Integrative Genomics Viewer (IGV)) of normalized read counts of selected genes in stMg or cbMg by TRAP. Numbers in brackets indicated minimum and maximum values of y axis shown for each gene. RPKM, reads per kilobase of transcript per million mapped reads. *P ≤ 0.05.
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surveillance proteins 14, 15 , including those that mediate G-proteincoupled chemosensing, chemotaxis, GTP signaling, and actin polymerization 20 (Fig. 1d ,e, Supplementary Fig. 5a ,b, and Supplementary Table 3 ). A large fraction of the cbMg-enriched genes, including Apoe, Axl, Colec12, Cd74, Lilrb4, Mrc1, and Ms4a7 ( Fig. 1d ,e, Supplementary Fig. 5a ,b, and Supplementary Table 3 ), encode proteins involved in apoptotic cell detection, cell engulfment, clearance of cell debris, and lipid and protein catabolism and have been shown to support clearance activity in phagocytic macrophages in peripheral tissues 21 . Furthermore, cbMg show an increase in the expression of genes characteristic of immature microglia 9,10 , as well as genes that are expressed in neurodegenerative diseaseassociated microglia (such as primed microglia, microglia with neurodegenerative phenotype, and disease-associated microglia) [11] [12] [13] ( Supplementary Fig. 5c,d and Supplementary Table 4 ). Notably, in contrast to neurodegenerative disease-associated microglia, cbMg are not enriched in the expression of pro-inflammatory genes such as Cxcl10, Il1b, Il6, and Tnf ( Supplementary Fig. 5b ). The differential cbMg clearance-gene versus stMg surveillancegene expression patterns were confirmed by microglia singlenuclei RNA-sequencing analysis ( Fig. 2a, 15 Counts per million stMg 2 10 2 10 cbMg-enriched genes
Mrc1
Axl (Fluidigm  C1) . Heatmap with unsupervised clustering displays the variation in the expression levels (z-score) of 75 most differentially expressed genes across all single nuclei. b, Bar graphs show normalized expression levels (counts per million) of selected genes for single stMg or cbMg nuclei. Experiment was repeated independently twice with similar results. c, Western blot analysis of CD11b-bead-isolated microglia (75,000 cbMg or stMg from 1 mouse per lane). Representative blots (left, cropped to show the specific band); ACTB is used as loading control. Right: quantifications (FSCN1: stMg: mean = 1.0, s.e.m. = 0.1887; cbMg: mean = 0.1792, s.e.m. = 0.08138; P = 0.0018, F = 5.378, t 11 = 3.994. MRC1: stMg: mean = 1.0, s.e.m. = 0.2132; cbMg: mean = 2.051, s.e.m. = 0.16; P = 0.0043, F = 1.776, t 8 = 3.941. AXL: stMg: mean = 1.0, s.e.m. = 0.3482; cbMg: mean = 11.79, s.e.m. = 2.691; P = 0.0018, F = 59.71, t 12 = 3.977. LC3: stMg: mean = 1.0, s.e.m. = 0.2328; cbMg: mean = 4.647, s.e.m. = 1.179; P = 0.0162, F = 25.66, t 8 = 3.034; two-tailed paired t test, n = 7 animals (4 independent experiments) for FSCN1 and AXL, n = 5 animals (2 independent experiments) for MRC1 and LC3). Full-length images of these blots and subsequent blots shown in Supplementary Fig. 15 . d, Schematic showing phagocytosis assay of acutely isolated adult cbMg or stMg exposed to early apoptotic cells in vitro. Quantification of the percentage of GFP + microglia that engulfed pHrodo + early apoptotic cells in presence or absence of phagocytosis inhibitor, Cytochalasin D (Cyt; stMg: mean = 9.055, s.e.m. = 1.761; stMg + Cyt: mean = 0.5725, s.e.m. = 0.3420; cbMg: mean = 24.63, s.e.m. = 0.3789; cbMg + Cyt: mean = 2.720, s.e.m. = 1.589; brain region: P < 0.0001, F = 53.36; Cyt: P < 0.0001, F = 156.9; two-way ANOVA, n = 4 independent experiments, each using four 3-to 4-month-old Cx3cr1 GFP/+ mice). Bar graphs with individual data points show mean ± s.e.m. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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( Supplementary Fig. 7a -c). The expression of selected cbMgenriched genes associated with clearance functions has been further validated at the level of protein expression. Expression of the clearance-associated proteins AXL, ApoE, CD74, MHCII, and MRC1 was significantly higher in cbMg, while actin polymerization-regulating FSCN1 protein expression showed a significant enrichment in stMg ( Fig. 2c and Supplementary Fig. 7d ). In support of cbMg clearance activity, we also found a significant enrichment in LC3 protein expression in cbMg as compared to in stMg ( Fig. 2c ). In addition to its known role in autophagy 22 , LC3 has been recently identified as a novel regulator of rapid apoptotic cell clearance in macrophages in a process termed LC3-associated phagocytosis, which occurs in the absence of immune activation 23 . Lastly, we found that adult cbMg display a significantly increased efficiency in the engulfment of apoptotic cells as compared to stMg (P = 0.0051). Co-incubation of acutely isolated cbMg and stMg from 3-to 4-month-old Cx3cr1 GFP/+ mice with apoptotic Jurkat cells ( Supplementary Fig. 7e ) resulted in increased apoptotic cell uptake by cbMg as compared to stMg ( Fig. 2d and Supplementary Fig. 7f ).
Cerebellar microglia are involved in the clearance of dying cells. The cerebellar microglia clearance phenotype, which is stably main-tained during adulthood ( Fig. 1d ), could reflect either an inherent region-specific feature of the cbMg and/or the activation of clearance function by exposure to dying cells. While the age-dependent loss of cerebellar mass and neuronal numbers 3, 4 implies ongoing cell death, we could not detect dying cells in the cerebellum of adult wild-type mice. We speculated that dying cells in the cerebellum are rapidly removed by microglia. In such a scenario, one would anticipate an increase in the number of apoptotic cells in the absence of microglia. Microglia can be efficiently ablated in mice by chronic treatment with PLX5622 (PLX), a pharmacological inhibitor of the colony stimulating factor 1 receptor, CSF1R, which is required for microglia survival 24 . Treatment of 2-month-old wild-type mice for > 3 weeks with PLX ( Supplementary Fig. 8a ) resulted in the near complete ablation of microglia (~99%) in the adult brain, including in the cerebellum and striatum ( Supplementary Fig. 8b ). The chronic depletion of microglia led to the accumulation of a significant number of apoptotic cells positive for cleaved-Caspase 3 (cCASP3) and TUNEL in the cerebellum but not in the striatum ( Fig. 3a and Supplementary Fig. 8c-e ). Co-labeling with different cell-type-specific markers revealed that the majority of the apoptotic cells were of neuronal origin and were distributed within all layers of the cerebellum ( Supplementary Fig. 9a,b ). The clearance 
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of dying cells by microglia was further supported by a substantial accumulation of cCASP3 + cells in the dentate gyrus and the olfactory bulb ( Supplementary Fig. 9c,d ), two brain regions displaying continuous neuronal turnover in the adult brain. At the same time, the lack of microglia did not lead to the appearance of cCASP3 + cells in the striatum or cortex ( Supplementary Fig. 9c,d) . In a complementary approach, we addressed the presence of apoptotic cells in the cerebellum of mice that lack the receptor tyrosine kinases Axl, and Mertk receptors, which regulate apoptotic cell detection and clearance by microglia 25 . We found that the combined deficiency of Axl and Mertk resulted in the accumulation of apoptotic cCASP3 + cells in the cerebellum of adult mice ( Fig. 3b ), suggesting that the presence of dying cells was not caused by the loss of microglia but reflected the attenuation of microglia clearance function. These data suggest that microglia are responsible for the continuous clearance of dying cells in the cerebellum and that the presence of dying cells may instruct the activation of cbMg clearance function.
Exposure to dying cells triggers the expression of clearance genes in microglia in vitro.
We found that exposure of primary forebrain microglia to apoptotic cells ( Supplementary Fig. 10a ) led to the progressive induction of numerous prophagocytic genes that were also enriched in cbMg ( Fig. 3c and Supplementary Fig. 10b ). This exposure to dying cells was associated with the time-dependent induction of cbMg-enriched transcription factors ( Fig. 3c and Supplementary   Fig. 10c ) and with the downregulation of stMg-enriched homeostatic surveillance genes ( Fig. 3c and Supplementary Fig. 10d ,e) in the absence of pro-inflammatory gene activation ( Supplementary  Fig. 10f ). Among the genes that were rapidly induced in microglia upon exposure to apoptotic cells were the cbMg-enriched Kdm6a and Kdm6b, which encode histone demethylases 26 ( Fig. 3c and Supplementary Fig. 10g ). KDM6A and KDM6B mediate the removal of the suppressive chromatin modification H3K27me3, which is associated with silenced genes 26 . Upregulation of Kdm6a/b and the associated induction of clearance genes in response to apoptotic cells are reminiscent of Kdm6a/b induction and H3K27me3 demethylation at inflammatory gene loci during macrophage activation 27, 28 . These findings point to a possible role for H3K27me3 in modulating brain-region-specific microglia clearance functions in vivo.
PRC2 controls a clearance-related gene-expression program in vivo.
H3K27me3 is mediated by PRC2, which has a well-established role in the regulation of cell differentiation during development 16 . Similarly to neurons and other cell types, microglia express all of the core components of PRC2: EZH1, EZH2, EED, and SUZ12 (data not shown). Enrichment of mRNAs encoding the H3K27me3-specific demethylases, KDM6A and KDM6B 26 , in cbMg (Supplementary Fig. 5b and Supplementary Table 3 ), as well as the upregulation of Kdm6a/b in microglia upon exposure to dying cells in vitro ( Fig. 3c and Supplementary Fig. 10g Fcer1g
Ms4a7 Ahr 
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and H3K27me3 in suppressing clearance-promoting genes in stMg. Genome-wide analysis of H3K27me3 distribution in ex vivo isolated microglial nuclei ( Fig. 4a ) showed that the majority of transcriptionally suppressed genes in microglia were associated with H3K27me3 ( Fig. 4b and Supplementary Fig. 11a ). The cbMg and stMg shared numerous loci targeted by H3K27me3 ( Supplementary Fig. 11b ,c and Supplementary Table 7 ). At the same time, we detected a substantial stMg-specific enrichment of H3K27me3 at the transcriptional start sites of cbMg-expressed clearance genes, including Axl, Ms4a7, and Adamts18, as well as on the cbMg-enriched transcription factors Rarg, Ahr, and Tead4 in stMg (Fig. 4c,d and Supplementary Table 7 ).
To address the role of PRC2-mediated H3K27me3 in the suppression of clearance genes, we inactivated PRC2 specifically in microglia. PRC2 inactivation was achieved by genetic ablation of EED, a core subunit of PRC2, which is essential for complex stability and catalytic activity 29 . To ablate EED specifically in adult microglia, we generated and bred Eed loxP/loxP mice, which carry a loxP-flanked Eed allele ( Supplementary Fig. 11d ), to Cx3cr1 CreErt2/+ mice to generate Cx3cr1 CreErt2/+ ;Eed loxP/loxP mice ( Fig. 5a ). Microglia-specific Eed ablation was induced by tamoxifen treatment from 4 to 6 weeks of age, to exclude any impact of PRC2 inactivation on microglia development ( Fig. 5a ).
Inactivation of Eed resulted in the complete and selective loss of H3K27me3 in microglia ( Fig. 5b-d ). We found that deficiency in Eed and the ensuing loss of H3K27me3 had no immediate impact on microglia activation but led to rather moderate and progressive changes in stMg gene expression between 3 and 9 months of age ( Fig. 5e,f ). About 50% of the genes that become progressively upregulated in Eed-deficient microglia were H3K27me3 + and hence were direct PRC2-target genes ( Fig. 5e , Supplementary Fig. 11e , and Supplementary Table 7 ). The deficiency in Eed and the ensuing loss of H3K27me3 led to the upregulation of several known PRC2 targets, such as Tbx15 and Hoxd8 30, 31 (Fig. 5g ,h, Supplementary Fig. 11f ,g, and Supplementary Tables 8 and 9 ), but did not affect the expression of genes that define microglia lineage identity ( Supplementary Fig. 11f ,g and Supplementary Tables 8 and 9) or genes characteristic of microglia pro-inflammatory activation ( Supplementary Fig. 11f ,g).
We found that PRC2 deficiency in stMg led to upregulation of genes that support clearance-related functions ( Fig. 5g , Supplementary Fig. 11f , and Supplementary Table 8 ), including numerous cbMg-enriched genes (44 of 215), such as Axl, Cd74, Alox15, and Samd9l, as well as transcription factors Rarg, Tfec, Ahr, and En2 ( Fig. 6a ,b, Supplementary Fig. 11g , and Supplementary Table 8 ). The loss of H3K27me3 and the upregulation of cbMgenriched clearance genes in Eed-deficient stMg were accompanied by a significant downregulation of a large number of stMg signature genes (313 of 643) implicated in the regulation of homeostatic surveillance functions 14, 15 (Fig. 6a,b , Supplementary Fig. 11g , and Supplementary Table 8 ). Most of these downregulated genes were H3K27me3and were, therefore, not directly controlled by PRC2 in stMg (Fig. 5e ). The increase in clearance-associated genes and the reduction in surveillance-related genes in PRC2-deficient stMg were reminiscent of transcriptional changes observed in microglia during neurodegenerative disease [11] [12] [13] ( Supplementary Fig. 11h ). The shift of stMg from a surveillance state toward a more clearancepromoting cbMg-like state ( Fig. 6a,b ), while not affecting overall microglia numbers or morphology ( Fig. 6c and Supplementary  Fig. 11i ), was associated with a significant increase in the stMg lysosomal content (Fig. 6c) .
In contrast to stMg, H3K27me3 was not present at clearancerelated gene loci in cbMg ( Fig. 4c,d ). Instead, H3K27me3 in cbMg was enriched on genes that are transcriptionally active in stMg. Accordingly, loss of PRC2 in cbMg, while following a similar temporal pattern of progressive PRC2 target gene induction ( Fig. 5f and Supplementary Fig. 11e ), was associated with the upregulation of selected stMg-enriched genes and the downregulation of cbMgenriched genes ( Fig. 6d,e ). The changes in PRC2-deficient cbMg gene expression patterns were associated with enhanced cbMgramification, a reduction in cbMg lysosomal content (Fig. 6f) , and an increased number of cCASP3 + cells in the cerebellum (Fig. 6g ). Collectively, our data point to a largely selective role of PRC2 in the maintenance of regional microglia specification in the adult brain, where it controls the cell-intrinsic suppression of an aberrant prophagocytic and clearance-like phenotype in stMg in vivo.
Aberrant expression of clearance-specific genes in striatal microglia has a negative impact on striatal neuron morphology and function.
We found that the switch in PRC2-deficient stMg from a surveillance phenotype to a more clearance-promoting phenotype had a profound impact on striatal medium spiny neuron (MSN) morphology and associated behaviors. Quantitative spine analysis of MSNs revealed a significant reduction in spine numbers in mice with Eed-deficient microglia as compared to controls ( Fig. 7a ). Notably, changes in MSN spine numbers were not caused by the overall negative effect of Eed-deficient microglia on MSN survival. Deficiency in Eed had no effect on the overall size and morphology of the striatum (data not shown), MSN density ( Supplementary  Fig. 12a ), or survival as defined by the presence of cCASP3 + cells ( Supplementary Fig. 12b ).
The changes in spine density of MSNs were associated with alterations in specific MSN-controlled behaviors. MSNs are involved in the regulation of complex behaviors that include control of motor activity, mood, and reward. While Cx3cr1 CreErt2/+ ;Eed loxP/loxP mice displayed normal motor activity at baseline ( Supplementary Fig. 12c ), we found a significant reduction in MSN-mediated locomotor sensitization in response to increased dopamine levels upon chronic cocaine treatment ( Fig. 7b and Supplementary Fig. 12d ). The induction of behavioral locomotor sensitization in response to cocaine depends on the structural plasticity of MSNs and is associated with 
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lasting changes in MSN spine density 32 . PRC2 deficiency in cbMg, on the other hand, had no significant impact on cerebellar Purkinje cell spine numbers (P = 0.1905; Supplementary Fig. 12e ) or on cerebellum-dependent behaviors ( Supplementary Fig. 12f ).
As in the striatum, we found that loss of PRC2 activity in cortical microglia (cxMg) was associated with a similar switch toward a microglia clearance phenotype ( Supplementary Fig. 12g ), including an increase in cxMg lysosomal content ( Supplementary Fig. 12h ).
The changes in cxMg were associated with a reduction in cortical pyramidal neuronal spine density ( Supplementary Fig. 12i ) in the absence of changes to neuronal survival ( Supplementary Fig. 12j ).
Disorders accompanied by alterations in spine numbers, including neurodegenerative and neuropsychiatric disorders, are frequently associated with the development of anxiety and seizures 33 and cognitive decline 34 . Accordingly, we found that loss of PRC2 activity in microglia led to enhanced anxiety behavior in the open 
Gene Articles NaTuRE NEuROsCiENCE field ( Fig. 7c and Supplementary Fig. 13a ). Likewise, during an elevated plus maze experiment, mutant mice spent significantly more time in the closed compartment and significantly less time in the more stressful open compartment as compared to their littermate controls ( Fig. 7d and Supplementary Fig. 13b ,c). In both a novelobject recognition task and in a fear-conditioning experiment, mutant mice showed mild impairments in cognition and memory ( Supplementary Fig. 13d,e ). Furthermore, > 50% of the mutant mice developed recurrent seizures with advanced age ( Fig. 7e and Supplementary Fig. 13f ). While young Cx3cr1 CreErt2/+ ;Eed loxP/loxP and control mice did not display any notable seizure events before 10 months of age, we detected an increased frequency of handlinginduced tonic-clonic seizure episodes in aged mutant mice ( Fig. 7e and Supplementary Fig. 13f ). However, the seizures did not result in premature death in the mutant mice ( Supplementary Fig. 13g ). Notably, the anxiety and seizure phenotypes were not observed in 1-year-old wild-type mice that lived in the chronic absence of microglia (continuous PLX treatment starting at 1 month of age; Supplementary Fig. 13h-j) , which indicates that the behavioral changes were unlikely due to a general loss of microglia function but rather reflected the aberrant microglia clearance activity in the striatum and cortex.
Discussion
Comparative analysis of microglia gene expression patterns in the striatum and cerebellum suggests the existence of two markedly different microglia phenotypes. Analysis of brain-region-specific microglia heterogeneity requires a maximal approximation between the gene expression states in vivo and those obtained during various analytical procedures. We generated brain-region-specific gene expression signatures of microglia by 'extracting' microglial RNAs directly from mouse brain tissue. This approach is based on noninvasive TRAP of mRNAs from specific cell types of interest 19 and has several major advantages compared to the commonly used ex vivo microglia purification approaches. When comparing these approaches, we found that microglia isolation by fluorescence-activated cell sorting (FACS) led to the expression of numerous genes that were indicative of cell activation and that were barely detectable when measured by TRAP. In addition to the noninvasive nature of the TRAP approach, we applied a stringent bioinformatics step during data analysis that excluded genes not enriched in microglia as compared to the input brain tissue 19 (Methods) . Notably, this approach, while being well-suited to generate signatures of mRNAs enriched in microglia subpopulations in different brain areas, bears certain shortcomings, as it may omit genes that are shared between microglia, neurons, astrocytes, or other cell types in the specific region. These differences should be considered when comparing data generated by TRAP to those generated from purified microglia ( Supplementary Fig. 14a ).
Here we expanded the depth of the population-based microglia TRAP approach by using single-microglia RNA-sequencing analysis, which allowed further assessment of inter-and intrapopulational microglia diversity. We continued to adhere to less invasive approaches and used rapid nuclei purification from specific mouse brain regions followed by FACS-based isolation of the GFP + microglial nuclei. We found that microglia nuclei isolation, in contrast to whole-microglia cell purification, diminished aberrant microglia activation. The cross-comparison between the microgliaregion-specific TRAP and single-nuclei-based RNA-expression patterns confirmed the distinct clearance-supporting phenotype in cbMg. Moreover, single-microglia nuclei-based analysis allowed us to exclude perivascular macrophages (Cx3cr1 + , Tmem119 -, and P2ry12 low ) 35 as potential factors driving the cbMg clearance-promoting gene expression signature.
In particular, a large fraction of the cbMg-expressed genes have been implicated in the detection, engulfment, and catabolism of debris both in peripheral macrophages carrying out cell clearance 21 , as well as in microglia associated with aging and neurodegeneration [11] [12] [13] . Recent evidence suggests that microglia can sense and clear apoptotic cells at the earliest stages of apoptosis 25 . This process, often referred to as efferocytosis, is a multistep process: (i) the recognition of 'eat me' signals presented by apoptotic cells, 
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(ii) engulfment of cells or debris, (iii) degradation of engulfed material, and (iv) excretion of metabolic products 21 . The numerous efferocytosis and clearance-associated genes expressed in cbMg comprise a set that encodes transcription factors implicated in the regulation of macrophage polarization, clearance, and differentiation, including AHR 36 , TFEC 37 , and RARG 38 . These transcription factors are also induced upon exposure to apoptotic cells, as well as in the Eed-deficient stMg, which acquired an aberrant clearance phenotype ( Supplementary Fig. 14b ).
Our findings suggest that the cerebellum displays relatively higher levels of cell loss as compared to the striatum or cortex. While dying cells in the adult cerebellum cannot be readily detected in the presence of microglia, we found that the ablation of microglia leads to an increase in the numbers of cCASP3 + apoptotic cells in Articles NaTuRE NEuROsCiENCE the cerebellum. This scenario is compatible with rapid microgliamediated removal of dying neurons in the subventricular zone 25 , as well as removal of apoptotic thymocytes during T cell development 39 . While most newly generated neurons and T cells undergo apoptotic cell death, the dying cells cannot be readily detected due to their rapid removal by resident macrophages/microglia 25, 39 . Consistent with this model, microglia in the cerebellum are likely to contribute to the effective removal of dying cells. Accordingly, we found that both deletion of microglia and attenuation of their cell-clearance capability were associated with the accumulation of dying cells in the cerebellum but not in the striatum or the cortex. The clearance activity of cbMg is further supported by recent liveimaging data from adult mice showing decreased parenchymal surveillance activity of cbMg as compared to forebrain microglia in vivo 40 . In parallel, we and others found that acutely isolated cbMg are much more efficient in the uptake of apoptotic cells or other biological materials 41 . Notably, while these data strongly imply the enhanced clearance activity of cbMg in the healthy brain, a comparative analysis that quantifies the levels of phagocytic activity in individual cbMg versus stMg in vivo is still needed. We found that the cbMg-specific clearance gene expression pattern significantly overlapped with the signature of microglia associated with neurodegeneration (P < 0.0001) [11] [12] [13] and early brain development (P < 0.0001) 9,10 , two stages of life characterized by enhanced neuronal attrition and heightened microglia clearance activity. In addition to the induction of cell clearance genes, the cbMg are further characterized by a clear reduction in homeostatic microglia genes 14, 15 . This is another key characteristic of early microglia progenitors 9,10 as well as of microglia exposed to dying neurons during different diseases [11] [12] [13] . Notably, one of the commonalities between the three previously discussed microglia phenotypes-microglia during early development, disease-associated microglia, and cbMg-is their likely active involvement in the clearance of apoptotic cells and cellular debris. Hence, we speculate that the similarities in their gene expression profiles may be driven by the activation of a microglia clearance function in response to dying cells.
While we consider the differential exposure to dying cells as a major contributor to regional microglia specification, we cannot fully exclude the potential impact of other cues, including regionspecific differences in neuronal activity, neurotransmitter release, and other microglia-recognized ligands 42 . However, in strong support of a causal contribution of ongoing cerebellar cell death to the induction of the cbMg clearance phenotype, we found that the exposure of forebrain microglia to dying cells in vitro led to a progressive induction of some key microglia cbMg-enriched clearance genes, 
Articles
NaTuRE NEuROsCiENCE
including Colec12, Lilrb4, and Apoe. Our findings are supported by data from Krasemann et al. 13 showing an induction of selected cbMg-enriched clearance genes in cortical microglia upon injection of dead cells into the healthy mouse brain in vivo ( Supplementary  Fig. 14c ). Overall, our data support the instructive nature of the cbMg phenotype, where continuous exposure to dying cells leads to the expression of genes that support cell clearance function. Our data also suggest that the exposure to and clearance of dying cells induces a distinct pattern of clearance-associated genes that is not intrinsically linked to the activation of pro-inflammatory genes. The lack of inflammatory gene activation in cbMg suggests that the microglia clearance activity may antagonize or suppress the activation of inflammatory genes in a fashion that has been observed in peripheral macrophages 21, 23 . In such a scenario, active clearance of cell debris in cbMg may lead to tolerance of cbMg against self, and thereby preclude potential damaging effects of an aberrant attack by activated cbMg on healthy cerebellar neurons. Consequently, there could be a mechanistic dissociation between the induction of clearance-gene expression and microglia pro-inflammatory activation observed during neurodegenerative diseases [11] [12] [13] , which may be mediated by additional cues from the local environment.
Our data also show that microglia clearance function, while important for the removal of dying cells, must be tightly controlled in other brain regions to avoid microglia-mediated damage of healthy neurons. We found that transcriptional silencing of some clearance-related genes correlated directly with abundance of the major suppressive histone modification H3K27me3 in stMg. The possible causal role of H3K27me3 in suppressing clearance-promoting genes in microglia is supported at several levels. First, clearancespecific genes display negligible amounts of H3K27me3 in cbMg as compared to in stMg. Moreover, exposure of forebrain microglia to dying cells in vitro increases the expression of H3K27me3specific demethylases, Kdm6a and Kdm6b, and is associated with progressive activation of cbMg-enriched clearance genes. While a potential demethylase-independent function of KDM6B cannot be excluded 43 , recent studies using a small molecule-based inhibitor specifically targeting KDM6A/B demethylase activity revealed that H3K27 demethylation and specifically KDM6A/B catalytic activity are critical determinants of pro-inflammatory gene activation in human primary macrophages 28 . Based on these data, it is plausible that clearance-gene expression in microglia is controlled in a KDM6A/B-H3K27me3-dependent fashion and that the induction of clearance genes is associated with a targeted reduction in H3K27me3 levels at specific clearance-gene loci in vivo.
Our data show that PRC2 plays an important role in the maintenance of region-specific functional specification of microglia. The lack of H3K27me3 leads to slow but progressive transcriptional changes in all Eed-deficient microglia subpopulations analyzed. The delay between the inactivation of PRC2 and PRC2-target gene induction in stMg, cxMg, and cbMg mimics our previous findings in neurons and is likely based on the combination of slow histone H3 protein turnover, as well as the slow catalytic activity of the H3K27me3 demethylases, KDM6A/B 31 . While following a similar temporal pattern, the nature of PRC2-controlled target genes differs among microglia subpopulations. In the striatum, deficiency in Eed leads to upregulation of specific clearance-associated genes and transcription factors. Only a small fraction of PRC2-controlled genes in stMg overlap with genes induced in PRC2-deficient cbMg or cxMg ( Supplementary Fig. 14d ).
Aberrant intrinsic activation of clearance phenotypes in PRC2deficient microglia in the striatum and cortex is associated with alterations in neuronal spines. The observed microglia-mediated reduction in spine numbers resembles the patterns of spine alterations caused by pathological microglia activation in mouse models of Alzheimer's disease 34 . While PRC2-deficient stMg and cxMg show no upregulation of complement or pro-inflammatory genes generally associated with microglia activation during neurodegeneration [11] [12] [13] 34 , it is still plausible that their aberrant clearance activity may lead to the enhanced engulfment of C1q-C3-tagged spines, the presence of which increases with age 44 . Aberrant synaptic pruning might also be mediated in a complement-independent fashion by Tyro3, Axl, and Merk receptors, which can bind exposed phosphatidylserine on synapses 45 . At the same time, it is possible that the reduction in spine density reflects the downregulation of stMg-enriched surveillance genes promoting spine formation and/ or maintenance in the adult brain 46 .
The ability of aberrant intrinsically activated microglia to cause neuronal damage is further supported by recent findings showing that cell-autonomous activation of the RAF-MEK-ERK pathway in microglia leads to the loss of synapses and the development of a severe, late-onset neurodegenerative disorder 7 . Notably, the RAF-MEK-ERK signaling cascade has been intrinsically linked to the regulation of PRC2 activity at several levels. While the loss of PRC2 activity is associated with reduced MEK-ERK activation in embryonic stem cells 47 , the inhibition of MEK-ERK activity leads to attenuated PRC2 chromatin association on PRC2-target genes in these cells 47 . On the other hand, increased activation of the MEK-ERK pathway has been linked to Ezh2 overexpression 48 . Increased EZH2 expression and activity is associated with a genome-wide redistribution of H3K27me3 that includes the loss of H3K27me3 and the transcriptional activation of numerous PRC2-suppressed genes in these cells 49 . Furthermore, aberrantly activated EZH2 was recently found to synergistically cooperate with hyperactive BRAF in the regulation of tumorigenesis 49 . Therefore, it is possible that neuronal damage caused by the aberrant activation of the RAS-MEK-ERK pathway in microglia may reflect a role of this pathway in PRC2mediated aberrant microglia clearance activity.
Our studies underscore the causal contribution of aberrant microglia clearance activation to neuronal damage and complex behavioral alterations associated with neurodegenerative and psychiatric disorders. The development of novel approaches to control microglia clearance activity via targeting specific epigenetic or signaling mechanisms may have therapeutic potential for the treatment of neurological diseases. Our studies may also have implications for understanding well-described brain-region-specific susceptibilities to different neurodegenerative disorders. For example, the cerebellum appears to be particularly resistant to Aβ accumulation and neurodegeneration in Alzheimer's disease 50 . It is tempting to speculate that the enhanced cbMg clearance activity may contribute to more efficient clearance of Aβ aggregates and damaged cells in the absence of inflammation.
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Animals. Mice were housed two to five animals per cage with a 12-h light/dark cycle (lights on from 0700 to 1900 h) at constant temperature (23 °C) with ad libitum access to food and water. All animal protocols were approved by IACUC at Icahn School of Medicine at Mount Sinai and were performed in accordance with NIH guidelines.
Eef1a1 LSL.eGFPL10a/+ mice 51 were crossed with Cx3cr1 CreErt2/+(Litt)52 , Cx3cr1 CreErt2/+(Jung) 53 , Tg(Prox1-Cre)SJ39 54 , Tg(Vav1-iCre) 55 , Tg(Csf1r-iCre) 56 , or Tg(Csf1r-Cre/Esr1*) 57 mice to obtain a microglia-specific TRAP mouse model. Tg(Vav1-iCre), Tg(Csf1r-iCre), and Tg(Csf1r-Cre/Esr1*) lines were excluded due to neuronal targeting, while the Cx3cr1 CreErt2/+ (Jung) line was excluded due to insufficient targeting of microglia. The Cx3cr1 CreErt2/+(Litt)52 line was selected for all subsequent experiments due to its highly efficient (> 99% of microglia) and microglia-specific Cre expression pattern throughout the brain. This was visualized by the expression of YFP driven by an internal ribosome entry site (IRES) following the CreErt2 gene. The expression of IRES-YFP did not interfere with microglia TRAP efficiency. The Tg(Prox1-Cre)SJ39 line showed highly efficient (> 99% of microglia) and exclusive microglia targeting in a limited number of brain regions, including the striatum and cerebellum. This line was used as an alternative TRAP line to ensure that region-specific gene expression changes were not caused by Cx3cr1 haploinsufficiency in the Cx3cr1 CreErt2/+(Litt) mice. Tg(Aldh1l1-eGFPL10a) 58 mice were used for astrocyte TRAP. R26 LSL.eYFP 59 reporter mice were used as a reporter of Cre expression. Cx3cr1 GFP/+ 60 mice were used for microglia imaging, phagocytosis assay, and GFP-based isolation of microglia. Wild-type mice were used for visualization and CD11bbased isolation of microglia. Cx3cr1 CreErt2/+(Jung)53 , Tg(Vav1-iCre) 55 , Tg(Csf1r-iCre) 56 , Tg(Csf1r-Cre/Esr1*) 57 , R26 LSL.eYFP 59 , Cx3cr1 GFP/+ 60 , and wild-type C57BL/6 mice were purchased from The Jackson Laboratory (stock numbers 020940, 008610, 019098, 021024, 006148, 005582, and 000664, respectively). Eef1a1 LSL.eGFPL10a/+ 51 , Cx3cr1 CreE rt2/+(Litt) 52 , Tg(Prox1-Cre)SJ39 54 , and Tg(Aldh1l1-eGFPL10a) 58 mice were generously provided by A. Domingos (Instituto Gulbenkian de Ciência, PT), D. Littman (NYU School of Medicine, NY), and N. Heintz (The Rockefeller University, NY), respectively.
To achieve conditional inactivation of the Eed gene, a loxP-flanked Eed allele was generated by gene targeting in embryonic stem cells, as shown in Supplementary Fig. 11c and described in detail elsewhere (A. Ebert and M. Busslinger, manuscript in preparation). In brief, exon 6 was chosen for gene deletion as a single base pair mutation in this exon was previously shown to disrupt the interaction of EED with EZH1/2 proteins, thus resulting in an Eednull phenotype 61, 62 . Exon 6 was extended by insertion of the remaining Eed cDNA sequence (exons 7-10) linked to a transcriptional STOP cassette consisting of six SV40 polyadenylation sites, and this extended exon was flanked by loxP recognition sequences to facilitate Cre-mediated deletion. A Gfp indicator gene linked to the 5′ part of Eed exon 6 was inserted downstream of the loxP-flanked Eed sequences such that Cre-mediated deletion led to splicing of exon 5 to the exon 6-Gfp exon, thus resulting in the expression of a GFP fusion protein reporting gene deletion. Routine genotyping of Eed loxP/loxP mice was performed using following primers:
• 5′ -GCGTTGCTTGTTTTAACCC • 5′ -ACTTCATCTCTGTGCCCTTCC • 5′ -CCACCTACACATGGGTTCTG • wild-type band: 840 bp • loxP-flanked band: 500 bp.
To achieve microglia-specific Eed-inactivation, microglia-specific Cx3cr1 CreErt2/+(Litt)52 mice were crossed to Eed loxP/loxP mice to generate Cx3cr1 CreErt2/+(Litt) ;Eed loxP/loxP mice. If not otherwise specified, Cx3cr1 CreErt2/+(Litt) ;Eed loxP/+ and Cx3cr1 CreErt2/+(Litt) ;Eed +/+ mice have been used as controls. Cx3cr1 CreErt2/+(Litt) ;Eed loxP/loxP mice were further crossed to Eef1a1 LSL.eGFPL10a/+ mice 51 to generate Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ ;Eed loxP/loxP mice. All mice used for experiments were backcrossed to the C57Bl/6 background for ≥ 5 generations.
To activate tamoxifen-inducible Cre (CreErt2 or Cre/Esr1*), mice were gavaged at 4-6 weeks of age with five doses of 100 mg/kg of tamoxifen (T5648, Sigma, St. Louis, MO) in corn oil (C8267, Sigma) with a separation of at least 48 h between doses.
For microglia ablation, 2-month-old wild-type or Cx3cr1 GFP/+ mice were treated with CSF1R inhibitor, PLX5622 (1,200 mg/kg chow, Plexxikon, Berkeley, CA), or vehicle for a minimum of 60 days.
Acute isolation of microglia by fluorescence-activated cell sorting (FACS).
Isolation of microglia from adult mice was adapted from Cardona et al. 63 . All mice were gavaged at 4-6 weeks of age with five doses of 100 mg/kg of tamoxifen with a separation of at least 48 h between doses. Mice were killed by CO 2 asphyxiation, and brain regions from Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ mice were dissected, cut into small pieces, and homogenized by manual compression between two glass slides in Hank's balanced salt solution (HBSS; 141175-095, Invitrogen Corporation, Carlsbad, CA) supplemented with 0.05% Collagenase D (1-088-874, Roche, Basel, CH), 25 mU/mL DNase I (Sigma), 0.5% Dispase II (165859, Roche), 10 μ L/mL RNasin (N2515, Promega, Madison, WI), and Superasin (AM2694, Applied Biosystems, Waltham, MA). The digestion reaction was incubated at 37 °C for 30 min with trituration through a 5mL pipette every 10 min and was stopped by addition of EDTA to a final concentration of 1 mM. The homogenate was centrifuged at 2,000g for 7 min at 4 °C; the pellet was resuspended in HBSS and filtered through a 100-μ m mesh filter. The centrifuge step was repeated once more, and the pellet was resuspended in 70% Percoll (17-0891-02, Amersham, Amersham, UK) in phosphate-buffered saline (PBS). A 50 mL Falcon tube was layered from bottom to top with the tissue in 70% Percoll, 37% Percoll, and PBS in 4:3:1 ratio. The Percoll gradient was centrifuged at 2,000g for 1 h at 4 °C in HS-4 Swinging Bucket Rotor (Life Technologies) in a Sorval RC 6 Plus Centrifuge (Life Technologies). The interphase containing the microglia was collected and resuspended in PBS with 2% normal goat serum supplemented with 10 μ L/mL RNasin, 10 μ L/mL Superasin and LIVE/DEAD Fixable Dead Cell Stain (Life Technologies, CA). Microglia were sorted using a BD FACSAria cell sorter (BD Biosciences, San Jose, CA, USA) by gating for high GFP signal and for low LIVE/ DEAD Fixable Dead Cell Stain. Sorted cells (50,000) were pelleted at 2,000g for 15 min at 4 °C. Genomic DNA was eliminated by RNase-Free DNase Set (Qiagen) following the manufacturer's instructions before RNA clean-up.
Acute isolation of adult microglia by CD11b expression. Adult microglia were isolated from 3-to 4-month-old wild-type (for protein isolation) or Cx3cr1 GFP/+ mice (for phagocytosis assay) using a protocol adapted from Bohlen et al. 64 Mice were killed by CO 2 asphyxiation, and brain regions were immediately removed. Tissue was enzymatically and mechanically dissociated using the Miltenyi neural dissociation kit (130-092-628, Miltenyi, Auburn, CA) following the manufacturer's recommendations. Myelin removal was performed using myelin removal beads II (130-096-733, Miltenyi) with LS columns (130-042-401, Miltenyi) following the manufacturer's recommendations. After myelin removal, the microglia were selected by anti-CD11b-coated microbeads (130-093-636, Miltenyi) with the QuadroMACs separator following the manufacturer's recommendations. Cells were manually counted with a hemocytometer using trypan exclusion staining and were either plated at 56,000/cm 2 in a 48-well plate with DMEM supplemented with 10% FBS (Sigma F4135) and 1% penicillin-streptomycin (Gibco 15140) for 5 h for phagocytosis assay or pelleted and immediately frozen on dry ice for protein isolation.
Primary neonatal microglia culture. Preparation of primary neonatal microglial cultures was adapted from Saura et al. 65 . Microglia were dissociated from mixed glial cultures by mild trypsinization. Briefly, 0.08% trypsin + 0.35 mM EDTA (25200-072, Life Technologies, Somerset, NJ) in Dulbecco's modified Eagle medium (DMEM; 31330-038, Life Technologies) was applied to mixed cultures for 35 min to dissociate all cells but microglia. The trypsinization was stopped by diluting the trypsin with DMEM and immediately removing all medium on the plate. The remaining pure microglial population was incubated with 0.25% trypsin + 1 mM EDTA for 10 min, dissociated by vigorous pipetting, resuspended in culture media, and plated at 75,000/cm 2 for 24 h in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin.
Treatment of adult or neonatal microglia cultures with early apoptotic Jurkat cells (EAJ).
The Jurkat human T cell line was obtained from ATCC (TIB-152). Cultures were regularly tested negative for mycoplasma using a Lonza kit according to the manufacturer's instructions (MycoAlert LT-07). Jurkat cells were cultured in RPMI medium (Gibco 11875) supplemented with 10% FBS, 10 mM HEPES, and 1% penicillin-streptomycin. On the day of microglia treatment, Jurkat cells were transferred to fresh growth medium at 1 million/mL and treated with 1 μ M staurosporine for 3 h. After treatment, cells were collected and washed with 15 mL cold PBS by centrifugation at 400g for 10 min. Medium or PBS were discarded using pipettes. Cells were resuspended in PBS at 10 million/mL, and induction of apoptosis was verified using FITC-Annexin V/propidium iodide kit and LSR II flow cytometer (BD Biosciences). Staurosporine-treated Jurkat cells were ~70% positive for phosphatidylserine staining and ~95% negative for propidium iodide staining, identifying the major population as early apoptotic ( Supplementary Fig. 7e ).
For gene expression analysis, EAJ were added on primary neonatal cbMg/stMg cultures (from 3-to 4-month-old male and female mice) that were trypsinized 24 h earlier at a 1:1 ratio for 4, 12, and 24 h. For the phagocytosis assay, early apoptotic cells were labeled with 10 μ g pHrodo Red succinimidyl ester dye (Thermo Fisher Scientific, P36600) per 10 6 cells for 1 h at room temperature (RT, 22-26 °C) in the dark. The cells were then washed with PBS and resuspended in microglia medium at 10 million/mL. Primary microglia from the cerebellum and striatum of adult mice that were cultured for 5 h were given an equal number of pHrodo-labeled EAJ. Cell confluency was determined using IncuCyte Live-Cell Analysis System and Software (Essen BioScience, Ann Arbor, Michigan, USA). Cells pretreated with 2 μ M cytochalasin D (Sigma-Aldrich, C8273) for 30 min before and during the incubation of microglia with pHrodo-EAJ were used as a negative control. After 3 h, the supernatant was discarded and microglia were trypsinized. Pooled wells were collected in one tube, centrifuged at 400g for 5 min, and resuspended in 500 μ L 1% BSA in PBS with 1 μ g/mL DAPI and placed on ice. We recorded 10,000-20,000 events on an LSR II Flow Cytometer (BD Biosciences). To quantify the uptake of pHrodo-labeled EAJ, events were gated on the SSC-A and FSC-A to exclude debris and then on GFP + microglia to quantify the percent of GFP + pHrodo + cells. Data were analyzed; dot plots and histograms were generated using FCS Express 6 (De novo Software). Per experiment, minima of 434 and 453 and maxima of 3,672 and 3,087 cells (medians: 1,539 and 1,545) were counted from stMg and cbMg, respectively. Histogram plots were smoothed by 30% and normalized to peak values based on the number of gated cells. Two-way ANOVA was used to compare between brain regions and dead cell exposure.
Isolation of microglial nuclei by FACS.
Microglial nuclei from different brain regions of 4-/8-month-old Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ (ChIP sequencing, nuclear RNA sequencing, or single nuclei RNA sequencing), 2-/3-monthold Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ ;Eed loxP/loxP or Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL. eGFPL10a/+ ;Eed loxP/+ (western blotting) mice were isolated based on the eGFP-L10a fluorescence of newly formed ribosomes in the microglia nucleoli, as described in Kriaucionis et al. 66 . All mice were gavaged at 4-6 weeks of age with five doses of 100 mg/kg of tamoxifen with a separation of at least 48 h between doses. Briefly, mice were killed by CO 2 asphyxiation, and brain regions were quickly dissected and homogenized in 0.25 M sucrose, 150 mM KCl, 5 mM MgCl 2 , 20 mM tricine, pH 7.8, with a glass dounce homogenizer (1984-10002, Kimble Chase, Vineland, NJ). For RNA isolation, the homogenate was unfixed and all buffers were supplemented with 10 μ L/mL RNasin (Promega) and Superasin (Applied Biosystems). For chromatin immunoprecipitation, the homogenate was cross-linked with a final concentration of 1% formaldehyde for 8 min at room temperature (RT, 22-26 °C) and the reaction was quenched with 0.125 M glycine for 5 min at RT. All buffers were supplemented with 0.15 mM spermine, 0.5 mM spermidine, and EDTAfree protease inhibitor cocktail (11836170001, Roche). For protein and RNA extraction, the homogenate was unfixed. The homogenate was then spun through a 29% iodixanol cushion. The resulting nuclear pellet was resuspended in 0.25 M sucrose, 150 mM KCl, 5 mM MgCl 2 , 20 mM tricine, pH 7.8, supplemented with 10 μ M DyeCycle Ruby (V10304, Invitrogen) and 10% donkey serum (017-000-121, Jackson Immunoresearch, West Grove, PA). Microglial nuclei were sorted in a BD FACSAria cell sorter by gating for the lowest DyeCycle Ruby, which serves as an indicator of nuclei singlets, and high GFP signal. For single-nuclei RNA sequencing, isolated nuclei were used immediately. For bulk nuclei sequencing (50,000), protein lysate preparation (50,000), and chromatin immunoprecipitation (500,000), nuclei were pelleted at 2,000g for 15 min at 4 °C. For bulk RNA analysis, genomic DNA was eliminated using RNase-Free DNase Set (Qiagen) following the manufacturer's instructions before RNA clean-up.
Translating ribosome affinity purification (TRAP). This approach relies on the genetic labeling of the ribosomal protein L10a with the enhanced green fluorescent protein (eGFP) in a cell-type-specific fashion followed by eGFP-based immunoaffinity purification of the ribosome-associated mRNAs 19, 58 . To generate microglia-specific TRAP mice, mice that carry a loxP-flanked STOP cassette (LSL) upstream of the eGFP-L10a gene under the control of eukaryotic translation elongation factor 1 alpha 1, Eef1a1 (Eef1a1 LSL.eGFPL10a ) 51 , were bred to mice that express the Cre recombinase under the control of the microglia-/macrophagespecific gene promoter, Cx3Cr1 52,53 as well as Tg(Prox1-Cre)SJ39 mice 54 . Tg(Prox1-Cre)SJ39 mice show microglia-specific Cre-expression in a limited number of brain regions including the striatum and cerebellum. Cx3cr1 CreErt2/+ (Jung) ;Eef1a1 LSL.eGFPL10a/+ , Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ , and Tg(Prox1-Cre)SJ39;Eef1a1 LSL.eGFPL10a/+ mice were used for microglia-specific TRAP, while Tg(Aldh1l1-eGFPL10a) mice were used for astrocyte-specific TRAP. C57Bl/6J wild-type mice were used to test for nonspecific mRNA enrichment. Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ mice were preferred for all analyses since they resulted in higher enrichment of microglial mRNA in TRAP over the unbound fraction than Cx3cr1 CreErt2/+ (Jung) ;Eef1a1 LSL.eGFPL10a/+ mice. Tg(Prox1-Cre)SJ39;Eef1a1 LSL.eGFPL10a/+ mice were used to exclude any gene expression changes due to Cx3cr1 haploinsufficiency in Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL. eGFPL10a/+ mice. For TRAP from Eed-deficient microglia, Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL. eGFPL10a/+ ;Eed loxP/loxP mice were compared to Cx3cr1 CreErt2/+(Litt) ;Eef1a1 LSL.eGFPL10a/+ ;Eed loxP/+ sex-and age-matched littermate controls. All mice were gavaged at 4-6 weeks of age with five doses of 100 mg/kg of tamoxifen with a separation of at least 48 h between doses.
Ribosome-associated mRNA from microglia or astrocytes was isolated from each region as previously described 67 . Briefly, mice were killed by CO 2 asphyxiation at indicated ages, and brain regions of interest were dissected. All TRAP experiments-except those from the cortex-were performed using freshly isolated tissue. Cortices were frozen in liquid nitrogen and cxMg TRAP was performed on frozen tissue. Brain tissue from one mouse was immediately homogenized with a motor-driven Teflon glass homogenizer in ice-cold polysome extraction buffer (10 mM HEPES (pH 7.3), 150 mM KCl, 5 mM MgCl 2 , 0.5 mM dithiothreitol (Sigma) 100 μ g/mL cycloheximide (Sigma), EDTA-free protease inhibitor cocktail (Roche), 10 μ L/mL RNasin (Promega) and Superasin (Applied Biosystems). Homogenates were centrifuged for 10 min at 2,000g, 4 °C, to pellet large cell debris. NP-40 (EMD Biosciences, CA) and 1,2-diheptanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids, AL) were added to the supernatant at final concentrations of 1% and 30 mM, respectively. After incubation on ice for 5 min, the lysate was centrifuged for 10 min at 13,000g to pellet insoluble material. Goat anti-GFP (19C8 and 19F7, Antibody & Bioresource Core Facility, Memorial Sloan-Kettering, NY) and biotinylated Protein L (GenScript, Piscataway, NJ)-coated Streptavidin MyOne T1 Dynabeads (Invitrogen) were added to the supernatant, and the mixture was incubated at 4 °C with end-over-end rotation overnight. Beads were collected on a magnetic rack and washed four times with high-salt polysome wash buffer (10 mM HEPES (pH 7.3), 350 mM KCl, 5 mM MgCl 2 , 1% NP-40, 0.5 mM dithiothreitol, and 100 μ g/mL cycloheximide). RNA was purified from beads directly using RNeasy Mini Kit (Qiagen) following the manufacturer's instructions.
Quantitative PCR (qPCR). Primary microglia (270,000) were lysed in Trizol (Life Technologies, CA) for 5 min, and phase separation was performed using chloroform. RNA was precipitated in the presence of isopropanol, sodium acetate and Glycoblue (Life Technologies) at -80 °C overnight. The pellet was washed with ice cold 75% ethanol, air-dried, and resuspended in nuclease-free water. We used 20-30 ng RNA to make cDNA with a High-Capacity cDNA Reverse Transcription Kit (Life Technologies) following the manufacturer's recommendations. The cDNA was used directly for qPCR with TaqMan Gene Expression Master Mix (Life Technologies) following the manufacturer's recommendations. Probes
Cycle counts for mRNA quantification were normalized to Gapdh. Relative expression (∆ Ct) and quantification (RQ = 2 -∆Ct ) for each gene were calculated. Unpaired two-tailed t tests were used to compare biological replicates.
Bulk RNA sequencing. RNA clean-up from isolated microglial cells (50,000), TRAP samples, and 5% of the unbound fractions from TRAP samples was performed using RNeasy Mini Kit (Qiagen) following the manufacturer's instructions. RNA integrity was assayed using an RNA Pico chip on a Bioanalyzer 2100 (Agilent, Santa Clara, CA), and only samples with RIN > 9 were considered for subsequent analysis. Double-stranded cDNA was generated from 1-5 ng of RNA using Nugen Ovation V2 kit (NuGEN, San Carlos, CA) following the manufacturer's instructions. Fragments of 200 bp were obtained by sonicating 500 ng of cDNA per sample using the Covaris-S2 system (duty cycle: 10%, intensity: 5.0, bursts per second: 200, duration: 120 s, mode: frequency sweeping, power: 23 W, temperature: 5.5-6 °C; Covaris Inc., Woburn, MA). Subsequently, these fragments were used to produce libraries for sequencing by TruSeq DNA Sample kit (Illumina, San Diego, CA, USA) following the manufacturer's instructions. The quality of the libraries was assessed by 2200 TapeStation (Agilent). Multiplexed libraries were directly loaded on NextSeq 500 (Illumina) with high-output singleread sequencing for 75 cycles. Raw sequencing data was processed using Illumina bcl2fastq2 Conversion Software v2.17.
Bioinformatic analysis of bulk sequencing. Raw sequencing reads were mapped to the mouse genome (mm9) using the TopHat2 package (v2.1.0) 68 . Reads were counted using HTSeq-count (v0.6.0) 69 against the Ensembl v67 annotation. The read alignment, read count, and quality assessment using metrics, such as total mapping rate and mitochondrial and ribosomal mapping rates, were done in parallel using an in-house workflow pipeline called SPEctRA 70 . The raw counts were processed through a variance stabilizing transformation (VST) procedure using the DESeq2 package 71 to obtain transformed values that are more suitable than the raw read counts for certain data mining tasks. Principal component analysis (PCA) was performed on the top 500 most-variable genes across all samples based on the VST data to visually assess whether there were any outliers. Additionally, hierarchical clustering was used to assess the outliers once again to protect against false positives/negatives from PCA, and the outliers were further justified by the aforementioned quality control metrics as well as experimental metadata. After outlier removal, all pairwise comparisons were performed on the count data of entire gene transcripts using the DESeq2 package (v1.6.3) 71 .
For the comparison of microglia-to astrocyte-TRAP, a cutoff of adjusted P value < 0.05, fold-change > 5, and mean expression > 30 (DESeq2; n = 2 mice per cell-type and per region; 3-to 6-month-old males) was applied. To represent the most highly expressed cell-type-specific genes, a mean expression cutoff of > 125 was used. To obtain the top 50 genes for these cell types, a fold-change cutoff of > 20 was used and the top 50 genes by mean expression are shown as bar graphs. For the comparison of microglia-TRAP to isolated microglia, a cutoff of adjusted P < 0.05, fold-change > 10, and mean expression > 30 was applied (DESeq2; n = 2 mice per method and brain region; 3-to 6-month-old males). Additionally, for the TRAP samples, an enrichment cutoff of P < 0.05 and fold-change > 2 over their respective unbound fraction was applied. For microglia brain-region-specific TUNEL assay with immunofluorescence. Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay with immunofluorescence was done using In situ Cell Death Detection Kit, Fluorescein (11684795910, Sigma). Briefly, slides (prepared for immunofluorescence) from 4-month-old wild-type mice treated with PLX or control diet were washed with PBS and permeabilized with permeabilization solution: 0.1% Triton X-100 and 0.1% sodium citrate for 10 min at room temperature. Labeling was performed at 37 °C for 1 h. After labeling, immunofluorescence protocol was followed with anti-NeuN antibody to visualize neuronal nuclei. Single-plane images were taken under LSM780 Confocal Microscope (Zeiss) with 10× objective at 1× zoom and analyzed using Zen 2011 software.
Single-molecule RNA in situ hybridization with immunofluorescence. At 6 weeks of age, Cx3cr1 GFP/+ mice were anesthetized with ketamine (120 mg/kg) and xylazine (24 mg/kg) and perfused transcardially with 10 mL PBS followed by 40mL 10% formalin in PBS. The brains were then removed and fixed in 10% neutralbuffered formalin for another 48 h. Fixed brains were embedded in paraffin, sectioned at 5 µ m, mounted on Superfrost Plus slides (Fisher Scientific, Hampton, NH), baked in a dry oven for 1 h at 60 °C, and stored at room temperature until further processing. In situ hybridization was carried out using RNAScope customdesigned probes for Mrc1, Apoe, Axl, Tfec, Ecscr, and Gpr56 in combination with the RNAScope 2.0 Red kit following the manufacturer's recommendations (Advanced Cell Diagnostics, Newark, CA). After completing in situ hybridization before colorimetric reaction, sections were rinsed with ddH 2 O and a gradient concentration of PBS [0.1× -1× ], blocked in 2% normal goat serum in PBS for 1 h at room temperature, and incubated with GFP antibody (1:500, ab6556, Abcam) in 2% normal goat serum in PBS overnight at 4 °C. GFP signal was amplified with anti-rabbit horseradish-peroxidase-conjugated secondary antibody and Alexa Fluor-488 tyramide from Tyramide Signal Amplification Kit (Life Technologies) following the manufacturer's instructions, and nuclei were stained with DAPI (0.2 mg/mL). Sections were then rinsed a gradient concentration of PBS [1× -0.1× ], and ddH 2 O, subjected to colorimetric reaction, dried for 15 min at 60 °C, mounted using EcoMount (EM897L, Biocare Medical, Concord, CA), and dried overnight. Single-plane images were taken under LSM780 Confocal Microscope (Zeiss) with 40× /1.3 oil objective at 0.6× zoom for quantification and > 4× for visualization and analyzed using Zen 2011 software. Single-plane images were also used as representative images.
Imaging quantification. The percent area of CD68 (lysosomes), CD74, MHCII, ApoE, AXL, IBA1, P2RY12, or GFP/YFP in brain sections from 4-/6-monthold wild-type and Cx3cr1 GFP/+ or 12-month-old Cx3cr1 CreErt2/+ ;Eed loxP/+ and Cx3cr1 CreErt2/+ ;Eed loxP/loxP mice was determined with ImageJ (National Institutes of Health) using the following image processing steps: (i) a binary image was created from the raw single-channel images, and (ii) the 'measure' function was used to determine the percentage area coverage of CD68, ApoE, AXL, CD74, MHCII, GFP/YFP, IBA1, CD11b, or P2RY12 (5-11 images from n = 2 or 3 mice). Percent area covered by a single microglia was calculated by dividing the percent area covered by microglia in an image by the total number of microglia in the same image. We analyzed 20-μ m z-stacked confocal images taken with 40× /1.3 oil objective at 1× zoom. DAPI + lysosomes in microglia from 4-/6-month-old wild-type mice were measured from 20-μ m z-stacked confocal images taken with 40× /1.3 oil objective at 1× zoom with Imaris (Bitplane, UK) using the following image processing steps: (i) microglia and lysosomes were reconstructed in 3D; (ii) DAPI signal outside the microglia surface was excluded; (iii) masked DAPI channel was reconstructed in 3D; and (iv) microglia with overlapping lysosome and DAPI surface were manually counted to exclude microglial nuclei (> 200 cells per region from n = 3 mice).
Microglia cell bodies from wild-type, Cx3cr1 CreErt2/+ ;Eed loxP/loxP mice, and control mice were counted manually from 3-6 20-μ m z-stacked confocal images taken with 40× /1.3 oil objective at 0.6× zoom from n = 3 mice per condition. cCASP3 + , TUNEL + , and Ki67 + cells were counted manually from olfactory bulb, striatum, somatosensory cortex, dentate gyrus, and cerebellum of 3-5 brain sections of n = 3 or 4 control, PLX-treated, and/or Axl −/− Mertk −/− mice. Cells with somas filled by cCASP3 and with pyknotic nuclei were counted as cCASP3 + . Cells with nuclei filled with Ki67 were counted as Ki67 + . H3K27me3 + cells were counted from 197-284 GFPand 50-55 GFP + cells from n = 2 mice per genotype. Counting for RNA in situ hybridization was done manually (50-73 cells from n = 2 mice).
Using Imaris software, we reconstructed 20-μ m z-stacked confocal images taken with 40× /1.3 oil objective at 1× zoom from n = 3-6 mice per condition, and DAPI + , CD68 + , and 200 IBA1 + microglia counted manually from n = 3 wild type mice.
The percentage of NeuN + cells was determined with ImageJ (National Institutes of Health) using the following image processing steps: (i) DAPI-stained nuclei were segmented by automated thresholding and particle analysis; (ii) each nucleus was then selected using the magic wand and transferred onto the NeuN-stained image by restore selection; (iii) fluorescence intensity for each cell was measured and tabulated, and the percentage of NeuN + cells was calculated using a mean intensity threshold > 15 (5-6 images from n = 2-3 mice).
Morphological analysis of microglia. We obtained 20-μ m z-stack images from 4-/6-month-old wild-type mice or 12-month-old Cx3cr1 CreErt2/+ ;Eed loxP/+ and Cx3cr1 CreErt2/+ ;Eed loxP/loxP mice on a Zeiss LSM780 Confocal Microscope with 40× /1.3 oil objective at 1× zoom at 2-µ m intervals and collapsed into 2D images. Neurolucida Explorer (MBF Bioscience, Williston, VT USA) was used to manually trace and generate analyses of microglia from the striatum and cerebellum. One microglial cell was selected per 0.045 µ m 2 of image. The cell body and soma were traced, and the thickness of each process was adjusted along its length. The number of primary processes and number of branch tips were measured. To account for a cell's complexity, Sholl analyses were performed for each cell. Concentric circles were spaced 10 µ m apart originating from the soma, and intersections of each cell with concentric circles were measured. We used n = 5 control animals for brain region comparisons; n = 3 mice/genotype were used to compare 15-month-old control and Cx3cr1 CreErt2/+ ; Eed loxP/loxP mice. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
